A key point was the news from Semler Scientific, a company operating in the medtech sector. By 2027, it plans to increase its bitcoin reserves from 4,449 BTC to 100,500 BTC.
To this end, the firm will raise funds through the issuance of convertible notes and the sale of shares. This strategy has been used before by Strategy and other major players.
Interest from major players
Analyst Valentin Fournier believes that Semler's initiative is an important signal of structural demand, despite the overall caution in the market. He noted that the company's market capitalization is still below the value of its bitcoin assets.
According to the analyst, the implementation of the plan could increase Semler's valuation by more than 20 times. This demonstrates the growing interest of corporations in digital gold and strengthens the thesis of institutional demand.
Interestingly, the U.S. Department of Justice has been investigating Semler's activities since 2017 regarding potential violations of the False Claims Act related to the QuantaFlo test.
Some experts see systemic threats in the situation, reminiscent of the 'phase of rapid growth and subsequent decline of 2021'. But here, bitcoin clearly acts as a reliable asset for investment. Peter Chang, head of research at Presto, believes that the current wave of corporate purchases looks more sustainable. According to him, companies are avoiding loans secured by cryptocurrencies. They prefer direct purchases, increasingly moving away from practices that previously exacerbated market downturns.
Valentin Fournier concluded that current conditions create a 'window for accumulating positions'. He expects further market growth as other companies follow Semler's lead.
'Current pessimism is an opportunity to buy ahead of new bullish catalysts,' the analyst summarized.